Mangrove Partners’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-200,000	Closed	-$3.06M	–	34
2014 Q1	$3.06M	Buy	+200,000	New	+$3.06M	1.02%	22